Zusammenfassung
Vitaminmangel-Erkrankungen sind häufig auftretende Krankheitsbilder, die mit sehr heterogenen Symptomen einhergehen können. In diesem Kapitel werden beispielhaft die Folgen eines Vitamin-B1- als auch eines Vitamin-B12-Mangels erläutert und ihre pathophysiologischen Mechanismen dargestellt. Es wird auf die Rolle der beiden B-Vitamine im Zellstoffwechsel eingegangen und die Pathomechanismen infolge eines Mangels an den Vitaminen dargelegt. Zudem wird auf die Ursachen der Mangelerkrankungen verwiesen, die zumeist im Rahmen von Unter- oder Fehlernährung auftreten oder Folge gastrointestinaler Störungen sind. Die Ursachen typischer neurologischer Syndrome infolge des Vitaminmangels werden dargestellt und Komplikationen als auch die Prognose der Erkrankungen diskutiert.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Literatur zu Abschn. 5.1
Afadlal S, Labetoulle R, Hazell AS. Role of Astrocytes in thiamine deficiency (2014) Metab Brain Dis 29: 1061–1068
Baker KG, Harding AJ, Halliday GM, Kril JJ, Harper CG (1999) Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke’s encephalopathy. Neuroscience 91 (2): 429–438
Desjardins P, Butterworth F (2005) Role of Mitochondrial Dysfunction and oxidative stress in the pathogenesis of selectve neuronal loss in Wernicke’s encephalopathy. Molecular Neurobiology 2005; 31: 17–25
Galvin R, Brathen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA (2010) EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 17 (12): 1408–1418
Harper C. Wernicke’s encephalopathy: a more common disease than realised. (1979) A neuropathological study of 51 cases. J Neurol Neurosurg Psychiat 42 (3): 226–231
Harper CG, Giles M, Finlay-Jones R (1986) Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiat 49 (4): 341–345
Hazell AS, Rama Rao KV, Canbolt NC, Pow DV, Butterworth RF (2001) Selective down-regulation of the astrocyte transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke’s encephalopathy. J Neurochem 78: 560–568
Kröll D, Laimer M, Borbely MB, Laederach K, Candinas D, Nett PC (2015) Wernicke Encephalopathy: A future problem even after sleeve Gastrectomy? A systematic review. Obes Surg 26 (1): 2015–212
Latt N, Dore G (2014) Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J 44 (9): 911–5.
Manzanares W, Hardy G (2011) Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care 14 (6): 610–617
Pittella JEH, Giannetti AV (1994) Morphometric study of the neurons in the medical mammillary nucleus in acute and chronic Wernicke’s encephalopathy. Clin Neuropathol 13 (1): 26–31
Qin L, Crews FT (2014) Focal thalamic degeneration from ethanol and thiamine deficiency is associated with neuroimmune gene induction, microglial activation and lack of Monocarboxylic Acid Transporters. Alcohol Clin Exp Res 38, 3: 657–671
Rodríguez-Pardo J, Puertas-Muñoz I, Martínez-Sánchez P, Díaz de Terán J, Pulido-Valdeolivas I, Fuentes B (2015) Putamina involvement in Wernicke encephalopathy induced by Janus Kinase 2 inhibitor. Clin Neuropharmacol 38 (3): 117–8
Scalzo SJ, Bowden SC, Ambrose ML, Whelan G, Cook MJ (2015) Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry
Schabelmann E, Kuo D (2012) Glucose before thiamine for Wernicke encephalopathy: A literature review. J Emerg Med 42 (4): 488–494
Sechi G, Serra A (2007) Wernicke’s encephalopathie: new clinical setting and recent advances in diagnosis and management. Lancet Neurol 6 (5): 442–55
Tran ND, Correale J, Schreiber SS, Fisher M (1999) Tranforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors. Stroke 30: 1671–1678
Literatur zu Abschn. 5.2
Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blicklé JF (2004) Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 171 (3): 251–259
Biesalski HK, Fürst P, Kasper H et al. (2004) Ernährungsmedizin. Nach dem Curriculum Ernährungsmedizin der Bundesärztekammer, 3. Aufl. Georg Thieme Verlag, Stuttgart
Biesalski HK, Köhrle J, Schümann K (2002) Vitamine, Spurenelemente und Mineralstoffe. Prävention und Therapie mit Mikronährstoffen. Georg Thieme Verlag, Stuttgart
Carmel R, Melnyk S, James SJ (2003) Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism. Blood 101 (8), 3302–3308
Durga J, van Boxtel MP et al. (2006) Folate and the methylenetetrahydrofolate reductase 677C -> T mutation correlate with cognitive performance. Neurobiol Aging 27 (2),334–343
Guéant JL, Caillerez-Fofou M, Battaglia-Hsu S, Alberto JM, Freund JN, Dulluc I, Adjalla C, Maury F, Merle C, Nicolas JP, Namour F, Daval JL (2013) Molecular and cellular effects of vitamin B12 in brain, myocardium and liver through its role as co-factor of methionine synthase. Biochimie 95 (5): 1033–40
Healton, EB, Savage, DG, Brust, JC, Garrett, TJ, Lindenbaum, J (1991) Neurologic aspects of cobalamin deficiency. Medicine70 (4), 229–245
Hacke W (Hrsg) (2016) Neurologie, 14. Auflage. Springer, Berlin Heidelberg New York
Heinrich PC, Müller M, Graeve L (Hrsg) (2014) Löffler/Petrides: Biochemie und Pathobiochemie, 9. Aufl. Springer, Berlin Heidelberg New York
Herrmann W, Lorenzl S, Obeid R (2007) Hyperhomocysteinämie und B-Vitaminmangel bei neurologischen und psychiatrischen Erkrankungen. Aktueller Kenntnisstand und vorläufige Empfehlungen. Fortschr Neurol Psychiatr 75 (9): e1-e18
Lindenbaum J, Healton EB et al. (1988) Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or acrocytosis. New Engl J Med 318 (26): 1720–1728
Linn J, Wiesmann M, Brückmann H (Hrsg) (2011) Atlas der klinischen Neuroradiologie des Gehirns. Springer, Berlin Heidelberg New York
Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26 (3): 137–146
Renard D, Dutray A, Remy A, Castelnovo G, Labauge P (2009) Subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia. Neurological Sci 30 (1), 75–76
Reynolds E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5 (11): 949–60
Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ (2003). Challenges in the identification of cobalamin-deficiency polyneuropathy. Archives of neurology,60 (9)1296–1301
Scalabrino G (2005) Cobalamin (vitamin B 12) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol 192 (2): 463–479
Singer MA, Lazaridis C, Nations SP, Wolfe GI (2008) Reversible nitrous oxide-induces myelinopathy with pernicious anemia: case report and literature review. Muscle Nerve 37: 125–129
Solomon LR (2007) Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 21: 113–130
Troen AM (2005) The central nervous system in animal models of hyperhomocysteinemia. Prog Neuro-Psychopharmacol Biol Psychiat 29 (7):1140–1151
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Biesalski, AS., Sturm, D. (2019). Vitaminmangel-Erkrankungen. In: Sturm, D., Biesalski, AS., Höffken, O. (eds) Neurologische Pathophysiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56784-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-56784-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56783-8
Online ISBN: 978-3-662-56784-5
eBook Packages: Medicine (German Language)